- The
company’s strategic partnerships expand its product placement, while its
white-labeling program captures additional market share
- ETST
is committed to improving women’s health worldwide with the launch of
Hygee
- The
company continues to explore expansion of product placement, both online
and in retail spaces
Florida-based biotech company Earth Science Tech Inc. (OTCQB: ETST) operates in the
fields of hemp cannabinoid, nutraceutical, pharmaceutical and medical device
research and development. The company’s focus on strategic partnerships and
becoming a global leader in the CBD sector, along with its commitment to
bringing cutting-edge pharmaceutical and medical-device offerings to market,
has put ETST in an intriguing position.
Strategic partnerships are key to ETST’s success. In
February 2019, the company announced (http://ibn.fm/jHVNM) its entry into agreements with
CannaBiz and Dessert Sun Distribution to provide high-grade, full-spectrum
products to pharmacies, chiropractors, dispensaries, athletic clubs and clinics
throughout the United States. The company has also created a way for other
marketers to rebrand ETST’s full-spectrum cannabinoids line following countless
white-labeling inquiries. By fulfilling these inquiries, the company is able to
capture even more market share.
ETST is committed to bringing cutting-edge pharmaceutical
and medical devices to market. Earth Science Pharmaceutical Inc., a wholly
owned subsidiary of ETST, is focused on offering low-cost diagnostic tools,
testing processes, medical devices and vaccines for women to detect and treat
sexually transmitted illnesses.
The company’s first medical device to market is Hygee.
Designed to detect STIs including chlamydia, Hygee is now ready for export, the
company reports. Queen Concept Inc. has entered into a distribution agreement
with ETST, making it the exclusive distributor of Hygee in Vietnam for the next
five years. Nearly 7.5 million women in Vietnam fall within the demographic
recommended for testing. Vietnam is the first of many countries that ETST is
targeting.
Chlamydia is a global issue, with an estimated 130 million
new cases diagnosed yearly. Diagnosing and treating chlamydia is particularly
important for pregnant women, as the disease can be passed to the baby during
childbirth. Following the launch of Hygee in Vietnam, marketing efforts will
target North America, South America, Asia and Africa. Hygee packaging will
feature English, French, Portuguese, Spanish, Vietnamese and Arabic in an
effort to reach the 1.5 billion people who claim one of those languages as
their mother tongue (http://ibn.fm/h2aEs).
ETST is dedicated to revolutionizing women’s health worldwide.
Operating through four wholly owned subsidiaries, the
company continues to explore expansion of product placement, both online and in
retail spaces, as it develops a world leader role in the CBD space.
“I’m excited to share that our sales during the past three
quarters have consistently increased over 100% every month,” ETST Chairman
Nickolas S. Tabraue stated in a news release (http://ibn.fm/0T0Ya). “We have also received countless
white-labeling inquires, and thanks to our reliable source and manufacturer, we
are now able to fulfill these inquires and capture even more market share. We
have a lot of opportunity on deck for 2019.”
For more information, visit the company’s website at www.EarthScienceTech.com
NOTE TO INVESTORS: The latest news and updates
relating to ETST are available in the company’s newsroom at http://ibn.fm/ETST
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
